Satiety, attention and concentration
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - BMI: 18,0 - 28,0 kg/m2 - Age: 18-50years - Men and Women - Written consent after information about study contents and study procedure - Ability and willingness of study participants to follow study leaders instructions
Exclusion criteria
Exclusion criteria: - severe chronic illness (manifest coronary heart disease, cancer) - severe kidney or liver diseases - insulin-dependent diabetes mellitus Typ I and II - continuous intake of corticosteroids (not inhalation), psychotropic drug - chronic gastroinestinal diseases (especially small intestine e.g. duodenal ulcer, liver, pancreas) - known endokrine and immunological diseases - Hormonal disorders, for example, hyperthyroidism and Cushing's syndrome - Treatment with non-insulin-releasing antidiabetics (guar, acarbose) -existing intolerances or allergies to ingredients of the diet - lactose or fructose malabsorption - intolerance towards soy and milk protein - continuous intake of laxatives - pregnancy - lactation - addiction to alcohol and/or drugs - immediate planned surgery - simultaneous participation at another clinical trial or participation within the last 30 days - missing consent or refusing / reset of the consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| attention and concentration measured by colour/word interfernce test (Stroop) 30 and 90 minutes after formula diet intake | — |
Secondary
| Measure | Time frame |
|---|---|
| satiety shall be measured via visual analogue scale before and 15, 30, 45, 60, 90 and 120 min after formula diet intake | — |
Countries
Germany
Contacts
oLeibniz Universität Hannover, Institut für Lebensmittelwissenschaft und Humanernährung, Abteilung Ernährungsphysiologie und Humanernährung